Анальгетики-антипиретики и нестероидные противовоспалительные средства в педиатрии: соотношение польза/риск и влияние на течение аллергических заболеваний

1. Bárzaga Arencibia Z. Choonara Balancing the risks and benefits of the use of over-the-counter pain medications in children. Drug Saf 2012; 35 (12): 1119–25.
2. Trajanovska M, Manias E, Cranswick N, Johnston L. Use of over-the-counter medicines for young children in Australia. J Paediatr Child Health 2010; 46 (1–2): 5–9.
3. Ушкалова Е.А., Астахова А.В. Проблемы безопасности Анальгина. Фарматека. 2003; 1: 74–9.
4. EMA post-authorisation evaluation of nimisulide (2004). http://www.ema.europa. eu/docs/en_GB/document_library/Referrals_document/Nimesulide_31/WC500013818.pdf
5. EMA Press Release – European Medicines Agency recommends restricted use of nimesulide-containing medicinal products (2009). http://www.ema.europa. eu/docs/en_GB/document_library/Press_release/2009/11/WC500011199.pdf
6. EMA Press Release – European Medicines Agency concludes review of systemic nimesulide-containing medicines (2011). www.ema.europa. eu/docs/en_GB /document_library/ Press_release/2011/06/WC500107903.pdf
7. Lee CH, Wang JD, Chen PC. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf 2010; 19 (7): 708–14.
8. Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis. Arch Pediatr Adolesc Med 2004; 158 (6): 521–6.
9. Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother 2010; 44 (3): 489–506.
10. Meremikwu M, Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Database Syst Rev 2002; 2: CD003676.
11. Autret E, Reboul-Marty J, Henry-Launois B et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. EurJ Clin 1997; 51: 367–71.
12. Pursell E. Treating fever in children: paracetamol or ibuprofen? Br J Community Nurs 2002; 7: 316–20.
13. Van den Anker JN. Optimising the management of fever and pain in children. Int J Clin Pract (Suppl.) 2013; 178: 26–3.
14. Eustace N, O'Hare B. Use of nonsteroidal anti-inflammatory drugs in infants. A survey of members of the Association of Paediatric Anaesthetists of Great Britain and Ireland. Paediatr Anaesth 2007; 17 (5): 464–9.
15. Charles CS, Matt BH, Hamilton MM, Katz BP. A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy patient. Otolaryngol Head Neck Surg. 1997; 117: 76–82.
16. Holloway AM, Logan DA. Comparison of oral ibuprofen with oral paracetamol for pain relief following tonsillectomy in children. Anaesth Intens Care 1992; 20: 99–114.
17. Derkay CS, Wadsworth JT, Darrow DH et al. Tube placement: a prospective, randomized double-blind study. Laryngoscope 1998; 108 (1 Pt 1): 97–101.
18. Harley EH, Dattolo RA. Ibuprofen for tonsillectomy pain in children: efficacy and complications. Otolaryngol Head Neck Surg 1998; 119 (5): 492–6.
19. Baygin O, Tuzuner T, Isik B et al. Comparison of pre-emptive ibuprofen, paracetamol, and placebo administration in reducing post-operative pain in primary tooth extraction. Int J Paediatr Dent 2011; 21 (4): 306–13.
20. Gazal G, Mackie IC. A comparison of paracetamol, ibuprofen or their combination for pain relief following extractions in children under general anaesthesia: a randomized controlled trial. Int J Paediatr Dent 2007; 17 (3): 169–77.
21. Rainsford KD, Roberts SC, Brown S. Ibuprofen and paracetamol: relative safety in non-prescription dosages. J Pharm Pharmacol 1997; 49: 345–76.
22. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999; 104: E39.
23. Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract (Suppl.) 2003; 135: 9–12.
24. Геппе Н.А. Место ибупрофена в жаропонижающей терапии детей с аллергическими состояниями. Cons. Med. Педиатрия (Прил.) 2003; 1: 39–41.
25. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA 1995; 273: 929–33.
26. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109 (2): E20.
27. Kanabar D, Dale S, Rawat M. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms. Clin Ther 2007; 29 (12): 2123–716.
28. Etminan M, Sadatsafavi M, Jafari S et al. Acetaminophen use and the risk of asthma in children and adults: a systematic review and meta-analysis. Chest 2009; 136 (5): 1316–23.
29. McBride JT. The association of acetaminophen and asthma prevalence and severity. Pediatrics 2011; 128 (6): 1181–5.
30. Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin 2009; 25 (9): 2207–22.
31. Nahata MC, Powell DA, Durrell DE, Miller MA. Acetaminophen accumulation in pediatric patients after repeated therapeutic doses. Eur J Clin Pharmacol 1984; 27 (1): 57–9.
32. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998; 132 (1): 22–7.
33. Muñiz AE, Rose SR, Liner SR, Foster RL. Unsuspected acetaminophen toxicity in a 58-day-old infant. Pediatr Emerg Care 2004; 20 (12): 824–8.
34. Savino F, Lupica MM, Tarasco V et al. Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant. Pediatrics 2011; 127 (2): e494–7.
35. Arundel C, Lewis JH. Drug-induced liver disease in 2006. Curr Opin Gastroenterol 2007; 23 (3): 244–54.
36. King JP, Davis TC, Bailey SC et al. Developing consumer-centered, nonprescription drug labeling a study in acetaminophen. Am J Prev Med 2011; 40 (6): 593–8.
37. Squires RH Jr, Shneider BL, Bucuvalas J et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148 (5): 652–8.
38. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration 1998–2005. Arch Intern Med 2007; 167 (16): 1752–9.
39. Bell LN, Chalasani N. Epidemiology of Idiosyncratic Drug-Induced Liver Injury. Semin Liver Dis 2009; 29 (4): 337–47.
40. Mathieu-Nolf M. Mathieu D. Acute poisonings: general management and main causes. Rev Prat 2010; 60 (6): 865–75.
41. Bannwarth B, Péhourcq F. Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues. Drugs 2003; 63 (2): 5–13.
42. Anderson BJ, Woollard GA, Holford NHG. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br JClin Pharmacol 2000; 50: 125–34.
43. Anderson BJ, van Lingen RA, Hansen TG. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 2002; 96 (6): 1336–45.
44. Muñiz AE, Rose SR, Liner SR, Foster RL. Unsuspected acetaminophen toxicity in a 58-day-old infant. Pediatr Emerg Care 2004; 20 (12): 824–8.
45. Anderson B. Paracetamol. In: E.Jacqz-Aigrain, I.Choonara, editors. Paediatric Clin Pharmacol. New York: Taylor & Francis, 2006; p. 621–7.
46. Bilenko N, Tessler H, Okbe R et al. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study. Clin Ther 2006; 28 (5): 783–93.
47. Gonzales K. Medication administration errors and the pediatric population: a systematic search of the literature. J Pediatr Nurs 2010; 25 (6): 555–65.
48. Krenzelok EP. The FDA Acetaminophen Advisory Committee Meeting – what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol (Phila) 2009; 47 (8): 784–9.
49. Sobhani P, Christopherson J, Ambrose PJ, Corelli RL. Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe. Ann Pharmacother 2008; 42 (1): 46–52.
50. Ryu GS, Lee YJ. Analysis of liquid medication dose errors made by patients and caregivers using alternative measuring devices. J Manag Care Pharm 2012; 18 (6): 439–45.
51. Rivera-Penera T, Gugig R, Davis J et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130: 300–4.
52. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998; 132 (1): 22–7.
53. Wallace LS, Keenum AJ, Devoe JE et al. Women's Understanding of Different Dosing Instructions for a Liquid Pediatric Medication. J Pediatr Health Care 2012; 26 (6): 443–50.
54. Beckett VL, Tyson LD, Carroll D et al. Accurately administering oral medication to children isn't child's play. Arch Dis Child 2012; 97 (9): 838–41.
55. Yin HS, Dreyer BP, Foltin G et al. Association of low caregiver health literacy with reported use of nonstandardized dosing instruments and lack of knowledge of weight-based dosing. Ambul Pediatr 2007; 7: 292–8.
56. Yin HS et al. Parents' medication administration errors: role of dosing instruments and health literacy. Arch Pediatr Adolesc Med 2010; 164 (2): 181–6.
57. Simon HK, Weinke DA. Over the counter medications: do parents give what they intend to give? Arch Pediatr Adolesc Med 1997; 151654–6.
58. Samuels-Kalow ME, Stack AM, Porter SC. Parental language and dosing errors after discharge fr om the pediatric emergency department. Pediatr Emerg Care 2013; 29 (9): 982–7.
59. Brune K, Hinz B, Otterness I. Aspirin and acetaminophen: should they be available over the counter? Curr Rheumatol Rep 2009; 11 (1): 36–40.
60. Lundstrøm KE. Ibuprofen is more effective than paracetamol in lowering the temperature in febrile children. Ugeskr Laeger 2012; 174 (18): 1214–7.
61. Maguire TA. Ibuprofen: a model medicine for self-care of common conditions. Int J Clin Pract (Suppl.) 2013; 178: 43–6.
62. Chiappini E, Principi N, Longhi R et al. Management of fever in children: summary of the Italian Pediatric Society guidelines. Clin Ther 2009; 31 (8): 1826–43.
63. Allan GM, Ivers N, Shevchuk Y. Treatment of pediatric fever: Are acetaminophen and ibuprofen equivalent? Can Fam Physician 2010; 56 (8): 773.
64. Mennick F. Ibuprofen or acetaminophen in children? As the debate continues, the evidence may favor ibuprofen. Am J Nurs 2004; 104 (9): 20.
65. Hay AD, Costelloe C, Redmond NM et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ 2008; 337: a1302.
66. Michels SL, Collins J, Reynolds MW et al. Over-the-counter ibuprofen and risk of gastrointestinal bleeding complications: a systematic literature review. Curr Med Res Opin 2012; 28 (1): 89–99.
67. Rainsford KD. Ibuprofen: from invention to an OTC therapeutic mainstay. Int J Clin Pract (Suppl.) 2013; 178: 9–20.
68. Bjarnason I. Gastrointestinal safety of NSAIDs and over-the-counter analgesics. Int J Clin Pract (Suppl.) 2013; 178: 37–42.
69. Морозова Т.Е., Андрущишина Т.Б., Антипова Е.К. Ибупрофен: безопасность и эффективность применения в широкой клинической практике. Терапевт. архив 2013; 3: 118–12.
70. Геппе Н.А. Первая международная конференция по применению ибупрофена в педиатрии. РМЖ. 2002; 10 (18): 831–5.
71. Heubi JE, Bien JP. Acetaminophen use in children: More is not better. J Pediatr 1997; 130 (2): 175–7.
72. Alander SW, Dowd D, Bratton SL, Kearns GL. Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med 2000; 154: 346–50.
73. Volans G, Monaghan J, Colbridge M. Ibuprofen overdose. Int J Clin Pract (Suppl.) 2003; 135: 54–60.
74. Hunter LJ, Wood DM, Dargan PI. The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose. Open Access Emergency Medicine 2011; 3: 39–48.
75. Haywood A. Pharmaceutical excipients – wh ere do we begin? Aust Prescr 2011; 34: 112–4.
76. Mennella JA, Beauchamp GK. Optimizing oral medications for children. Clin Ther 2008; 30 (11): 2120–32.
77. Autret-Leca E, Gibb IA, Goulder MA. Ibuprofen versus paracetamol in pediatric fever: objective and subjective findings from a rando­mized, blinded study. Curr Med Res Opin 2007; 23 (9): 2205–11.
78. Hadas D, Youngster I, Cohen A et al. Premarketing surveillance of ibuprofen suppositories in febrile children. Clin Pediatr (Phila) 2011; 50 (3): 196–9.
79. Бисли Р., Клейтон Т., Крейн Д. и др. Связь между использованием парацетамола у новорожденных и детей с риском возникновения бронхиальной астмы, риноконъюнктивита и экземы у детей 6–7-летнего возраста: анализ данных, полученных в ходе третьей фазы программы ISAAC. Lancet 2008; 372: 1039–48.
80. Kidon MI, Kang LW, Chin CW et al. Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in Preschool Children. Allergy, Asthma, Clin Immunol 2007; 3 (4): 114–22.

Е.А.Ушкалова

Кафедра общей и клинической фармакологии ФГБОУ ВПО РУДН, Москва